Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
30 Leser
Artikel bewerten:
(0)

Global Enteral Feeding Formulas Market - Estimated to Reach USD 5.95 Billion by 2020

DUBLIN, March 16, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/8xxn58/enteral_feeding) has announced the addition of the "Enteral Feeding Formulas Market - Global Forecast to 2020" report to their offering.

The global enteral feeding formulas market is estimated to reach USD 5.95 Billion by 2020, growing at a CAGR of 7.6% during the forecast period.

The market is mainly driven by the rising incidences of chronic diseases and disorders, the rapidly increasing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. On the other hand, factors such as complications associated with enteral nutrition, patient safety risks, and the risk of feeding and medication errors are some factors that are expected to limit the growth of the enteral feeding formulas market in the coming years.

The global enteral feeding formulas market is segmented on the basis of product, stage, application, end user, and region.

North America and Europe are expected to witness a healthy growth rate in the coming years, owing to the rapidly growing geriatric population along with rising incidences of chronic diseases and disorders, increasing healthcare expenditure, and increasing demand for homecare.

The Asia-Pacific region, on the other hand, represents the fastest-growing market for enteral feeding formulas. The high growth rate in this market is primarily attributed to the presence of a large patient pool for chronic diseases and disorders, increasing incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and a rapidly increasing population in the emerging APAC countries.

Companies Mentioned:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Danone S.A.
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson Nutrition Company
  • Meiji Holdings Co., Ltd.,
  • Nestlé S.A.
  • Victus, Inc.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Global Enteral Feeding Formulas Market, By Stage

8 Global Enteral Feeding Formulas Market, By Product

9 Global Enteral Feeding Formulas Market, By Application

10 Global Enteral Feeding Formulas Market, By End User

11 Global Enteral Feeding Formulas Market, By Region

12 Competitive Landscape

13 Company Profiles

For more information visit http://www.researchandmarkets.com/research/8xxn58/enteral_feeding

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.